Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2014 08:34 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Establishes Office in Geneva, Switzerland

SAN FRANCISCO and GENEVA, May 6, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
May 05, 2014 14:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Acquires Additional Rights to LymPro Test From Memory Dx

SAN FRANCISCO, May 5, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics...
May 01, 2014 11:45 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Positive Independent Peer-Reviewed Preclinical Data for MANF in Alzheimer's and Diabetes

SAN FRANCISCO, May 1, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics...
April 28, 2014 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus CSO to Present on PhenoGuard Data at Astrocytes in Health and Neurodegenerative Disease in London

SAN FRANCISCO, April 28, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
April 21, 2014 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces 2013 Year End Financial Results

SAN FRANCISCO, April 21, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
April 08, 2014 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Dr. Charlotte Keywood Chief Medical Officer of Its Therapeutics Division

SAN FRANCISCO, April 8, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
April 01, 2014 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer

SAN FRANCISCO, April 1, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
March 31, 2014 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Dr. Louis Kirby to Board of Advisors

SAN FRANCISCO, March 31, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
March 26, 2014 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Cavendish Selects Amarantus to Present at the Cavendish Global Health Impact Forum

SAN FRANCISCO and NEW YORK, March 26, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics...
March 10, 2014 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC

SAN FRANCISCO, March 10, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTC:AMBS) (Amarantus or the Company), a biotechnology company focused on the discovery and development of novel...